Dendritic Cell Vaccines + Dasatinib for Metastatic Melanoma
Clinical trial NCT01876212 · COMPLETED
Trial details
- NCT number
- NCT01876212
- Sponsor
- Walter J. Storkus
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-16
- Primary completion
- 2018-07-11
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.